| European Federation of Biotechnology | |
| Abbreviation: | EFB |
| Formation: | 1978 |
| Founding Location: | Barcelona, Spain |
| Purpose: | Promote biotechnology |
The European Federation of Biotechnology (EFB) was established by European scientists in 1978. It is a non-profit federation of national biotechnology associations, learned societies, universities, scientific institutes, biotechnology companies and individual biotechnologists working to promote biotechnology throughout Europe and beyond.
Its mission is to promote the safe, sustainable and beneficial use of life sciences, to promote cutting edge research and innovation, to provide a forum for interdisciplinary and international cooperation, to improve scientific education and to facilitate an informed dialogue between scientists, the biotechnology industries and the public.
The EFB has around 25,000 individual members and 7 Divisions that focus on:
The EFB Central Office (ECO) is located in Barcelona.[1]
The European Congress on Biotechnology (ECB) is a conference for academic and industrial biotechnologists, organised by EFB.
The first Congress was held in 1978. The event is held every second year.[2]
The EFB, together with its Divisions, organises specialised biotechnology events, such as :
EFB Bioeconomy Journal covers the science, natural and social sciences, the technologies and the humanities related to bioeconomy and its surrounding political, business, ethics, regulatory, social, and financial milieu. The peer-reviewed journal publishes original research papers, authoritative reviews, feature articles and opinions. It seeks out advances in research and technologies, such as ideas that open opportunities for exploitation of knowledge, commercially or otherwise, together with news, discussion, and comment on broader issues of general interest and concern.
New Biotechnology is EFB's official bimonthly journal. It covers biotechnology and its surrounding political, business and financial milieu. The peer-reviewed journal publishes basic research papers, authoritative reviews, feature articles and opinions in all areas of biotechnology. It emphasizes advances in research and practice that open opportunities for exploitation of knowledge, commercially or otherwise, together with news, discussion and comment on broader issues.